Heart MRI may spot deadly side effect of immunotherapy early
NCT ID NCT05125965
First seen May 02, 2026 · Last updated May 07, 2026 · Updated 2 times
Summary
This study looks at whether cardiac MRI can detect heart inflammation (myocarditis) early in cancer patients receiving immunotherapy. Myocarditis is a rare but serious side effect that can be fatal. The goal is to improve diagnosis and potentially save lives by catching it sooner. The study involves 200 adults who are having a cardiac MRI for suspected heart complications from their cancer treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Chirurgical Marie Lannelongue
Le Plessis-Robinson, 92350, France
-
Hopital Paris Saint Joseph
Paris, 75014, France
-
Hôpital Europeen Marseille
Marseille, 13003, France
Conditions
Explore the condition pages connected to this study.